Literature DB >> 9268008

A new type of chemical modification of glycopeptides antibiotics: aminomethylated derivatives of eremomycin and their antibacterial activity.

A Y Pavlov1, E I Lazhko, M N Preobrazhenskaya.   

Abstract

A series of derivatives of eremomycin aminomethylated at the 7d position of the resorcinol ring of the amino acid No. 7 was prepared by interaction of eremomycin with formaldehyde and various primary and secondary amines and ammonia. The most active compound obtained was 7d-decylaminomethyl derivative, whose minimal inhibitory concentrations for clinical isolates of staphylococci are 2 approximately 8 times lower than those of the parent antibiotic. 7d-Decylaminomethyl derivative was also active against vancomycin-resistant VanA enterococci (8 microg/ml) and Neisseria gonorrhoeae (16 microg/ml).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9268008     DOI: 10.7164/antibiotics.50.509

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  7 in total

1.  A stepwise dechlorination/cross-coupling strategy to diversify the vancomycin 'in-chloride'.

Authors:  Tyler J Wadzinski; Katherine D Gea; Scott J Miller
Journal:  Bioorg Med Chem Lett       Date:  2015-12-11       Impact factor: 2.823

Review 2.  Biological, chemical, and biochemical strategies for modifying glycopeptide antibiotics.

Authors:  Edward Marschall; Max J Cryle; Julien Tailhades
Journal:  J Biol Chem       Date:  2019-10-31       Impact factor: 5.157

3.  Structures of Staphylococcus aureus cell-wall complexes with vancomycin, eremomycin, and chloroeremomycin derivatives by 13C{19F} and 15N{19F} rotational-echo double resonance.

Authors:  Sung Joon Kim; Lynette Cegelski; Maria Preobrazhenskaya; Jacob Schaefer
Journal:  Biochemistry       Date:  2006-04-25       Impact factor: 3.162

4.  Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.

Authors:  Evgenia N Olsufyeva; Andrey E Shchekotikhin; Elena N Bychkova; Eleonora R Pereverzeva; Ivan D Treshalin; Elena P Mirchink; Elena B Isakova; Mikhail G Chernobrovkin; Roman S Kozlov; Andrey V Dekhnich; Maria N Preobrazhenskaya
Journal:  Drug Des Devel Ther       Date:  2018-09-10       Impact factor: 4.162

5.  Inhibition of feline (FIPV) and human (SARS) coronavirus by semisynthetic derivatives of glycopeptide antibiotics.

Authors:  Jan Balzarini; Els Keyaerts; Leen Vijgen; Herman Egberink; Erik De Clercq; Marc Van Ranst; Svetlana S Printsevskaya; Eugenia N Olsufyeva; Svetlana E Solovieva; Maria N Preobrazhenskaya
Journal:  Antiviral Res       Date:  2006-04-06       Impact factor: 5.970

Review 6.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

Review 7.  The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions.

Authors:  Bee Ha Gan; Josephine Gaynord; Sam M Rowe; Tomas Deingruber; David R Spring
Journal:  Chem Soc Rev       Date:  2021-07-05       Impact factor: 54.564

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.